HCG Bengaluru Hospital’s breakthrough in low dose immunotherapy for head and neck cancer
As part of the pilot study, a total of 12 cases were studied between the age group of 54 to 76 years. All twelve patients…
Recover your password.
A password will be e-mailed to you.